Specialty Urology
-
Featured
Active Surveillance for Prostate Cancer
In this video, Keyan Salari, MD, PhD, discusses his team's work to identify the features of seemingly indolent prostate cancers that actually make them more aggressive.
-
Featured
Mass General Offers Novel, Kidney-saving Urothelial Cancer Treatment
Mitomycin chemoablation with a mitomycin gel, a novel treatment offered in the Department of Urology at Massachusetts General Hospital, can avoid the need for surgical removal of the kidney and ureter in patients with upper tract urothelial cancer.
-
Primary Prostate Cancer Establishes a Suppressive Immune Microenvironment
Through careful unraveling of the cellular and molecular landscape of prostate cancer, Massachusetts General Hospital researchers observed a highly immune-suppressive tumor microenvironment with a pattern of angiogenic gene expression, findings that will help identify targets amenable to therapeutic interventions.
-
Review: Economic Burden of Non-Cancerous Genitourinary Conditions
The economic burden of non-cancerous genitourinary conditions in U.S. adults has not been well documented, Michelle M. Kim, MD, PhD, and colleagues found in a review of 14 conditions. They also offer suggestions for improving cost estimates.
-
De Novo Stress Urinary Incontinence Common After Laparoscopic Sacrocolpopexy
Youngwu Kim, MD, Emily Von Bargen, DO, and colleagues found that of 169 stress-continent women who underwent minimally invasive sacrocolpopexy, 30 (18%) developed stress urinary incontinence (SUI). An existing calculator for determining the risk of postoperative de novo SUI performed moderately well in the cohort.
-
Mortality Related to Surgical Staplers and Clip Appliers Is Increasing
Matthew F. Wszolek, MD, and colleagues present evidence from an FDA database suggesting the use of surgical staplers and clip appliers, especially in urologic, gastrointestinal, hepatic and spleen procedures, may be more dangerous to patients than previously appreciated.
Urology Contributors
-
Adam Scott Feldman, MD, MPH
Director, Combined Harvard Urologic Oncology Fellowship, Director of Research and Urologic Oncologist, Department of Urology, Massachusetts General Hospital
Recent Article
Review: Active Surveillance for Intermediate-risk Prostate Cancer
-
Ajay Nehra, MBBS
Director of Men's Health and Male Reconstructive Surgery, Senior Urologic Surgeon
Recent Article
Establishing Guidelines for Peyronie's Disease
-
Brian Howard Eisner, MD
Co-Director, Kidney Stone Program, Assistant Professor of Surgery, Harvard Medical School
Recent Article
Diabetes Not a Risk Factor for Septic Shock Among Patients With Ureteral Stone and UTI
-
Dianne E. Sacco, MD
Co-Director, Kidney Stone Program, Assistant Professor of Surgery, Harvard Medical School
-
Douglas Middleton Dahl, MD
Chief, Division of Urologic Oncology, Director of Robotic Surgery, Massachusetts General Hospital, Associate Professor of Surgery (Urology), Harvard Medical School
Recent Article
Genetic Signature Predicts Metastasis, Survival in Clear Cell Renal Cell Carcinoma
-
-
Keyan Salari, MD, PhD
Urologic Surgeon, Department of Urology, Massachusetts General Hospital, Urologic Oncologist, Mass General Cancer Center, Director, Prostate Cancer Genetics Program
Recent Article
Review: Biomarkers in Testicular Cancer
-
Matthew F. Wszolek, MD
Chair of Quality and Safety, Department of Urology, Massachusetts General Hospital, Urological Oncologist, Mass General Cancer Center, Instructor in Surgery, Harvard Medical School
Recent Article
Mortality Related to Surgical Staplers and Clip Appliers Is Increasing
Urology Care at Mass General
The Department of Urology at Massachusetts General Hospital offers sophisticated, compassionate care and the most innovative treatments for patients with any type of urological condition.